Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA
We performed antimicrobial drug susceptibility testing and molecular typing on invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 1,666) submitted to the University of Iowa Hygienic Laboratory during 1999–2006 as part of a statewide surveillance system. All USA300 and USA400 i...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2009-10-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/15/10/08-0877_article |
_version_ | 1818538270480400384 |
---|---|
author | Philip Van De Griend Loreen A. Herwaldt Bret Alvis Mary DeMartino Kristopher Heilmann Gary Doern Patricia Winokur Diana DeSalvo Vonstein Daniel Diekema |
author_facet | Philip Van De Griend Loreen A. Herwaldt Bret Alvis Mary DeMartino Kristopher Heilmann Gary Doern Patricia Winokur Diana DeSalvo Vonstein Daniel Diekema |
author_sort | Philip Van De Griend |
collection | DOAJ |
description | We performed antimicrobial drug susceptibility testing and molecular typing on invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 1,666) submitted to the University of Iowa Hygienic Laboratory during 1999–2006 as part of a statewide surveillance system. All USA300 and USA400 isolates were resistant to <3 non–β-lactam antimicrobial drug classes. The proportion of MRSA isolates from invasive infections that were either USA300 or USA400 increased significantly from 1999–2005 through 2006 (p<0.0001). During 2006, the incidence of invasive community-associated (CA)–MRSA infections was highest in the summer (p = 0.0004). Age <69 years was associated with an increased risk for invasive CA-MRSA infection (odds ratio [OR] 5.1, 95% confidence interval [CI] 2.06–12.64), and hospital exposure was associated with decreased risk (OR 0.07, 95% CI 0.01–0.51). |
first_indexed | 2024-12-11T21:26:52Z |
format | Article |
id | doaj.art-8a16127513f64300b7de906cb361ff38 |
institution | Directory Open Access Journal |
issn | 1080-6040 1080-6059 |
language | English |
last_indexed | 2024-12-11T21:26:52Z |
publishDate | 2009-10-01 |
publisher | Centers for Disease Control and Prevention |
record_format | Article |
series | Emerging Infectious Diseases |
spelling | doaj.art-8a16127513f64300b7de906cb361ff382022-12-22T00:50:19ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592009-10-0115101582158910.3201/eid1510.080877Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USAPhilip Van De GriendLoreen A. HerwaldtBret AlvisMary DeMartinoKristopher HeilmannGary DoernPatricia WinokurDiana DeSalvo VonsteinDaniel DiekemaWe performed antimicrobial drug susceptibility testing and molecular typing on invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 1,666) submitted to the University of Iowa Hygienic Laboratory during 1999–2006 as part of a statewide surveillance system. All USA300 and USA400 isolates were resistant to <3 non–β-lactam antimicrobial drug classes. The proportion of MRSA isolates from invasive infections that were either USA300 or USA400 increased significantly from 1999–2005 through 2006 (p<0.0001). During 2006, the incidence of invasive community-associated (CA)–MRSA infections was highest in the summer (p = 0.0004). Age <69 years was associated with an increased risk for invasive CA-MRSA infection (odds ratio [OR] 5.1, 95% confidence interval [CI] 2.06–12.64), and hospital exposure was associated with decreased risk (OR 0.07, 95% CI 0.01–0.51).https://wwwnc.cdc.gov/eid/article/15/10/08-0877_articleMethicillin-resistant Staphylococcus aureus infectionsMRSAcommunity-associated MRSAsurveillancebloodstream infectionIowa |
spellingShingle | Philip Van De Griend Loreen A. Herwaldt Bret Alvis Mary DeMartino Kristopher Heilmann Gary Doern Patricia Winokur Diana DeSalvo Vonstein Daniel Diekema Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA Emerging Infectious Diseases Methicillin-resistant Staphylococcus aureus infections MRSA community-associated MRSA surveillance bloodstream infection Iowa |
title | Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA |
title_full | Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA |
title_fullStr | Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA |
title_full_unstemmed | Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA |
title_short | Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA |
title_sort | community associated methicillin resistant staphylococcus aureus iowa usa |
topic | Methicillin-resistant Staphylococcus aureus infections MRSA community-associated MRSA surveillance bloodstream infection Iowa |
url | https://wwwnc.cdc.gov/eid/article/15/10/08-0877_article |
work_keys_str_mv | AT philipvandegriend communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT loreenaherwaldt communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT bretalvis communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT marydemartino communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT kristopherheilmann communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT garydoern communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT patriciawinokur communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT dianadesalvovonstein communityassociatedmethicillinresistantstaphylococcusaureusiowausa AT danieldiekema communityassociatedmethicillinresistantstaphylococcusaureusiowausa |